(PhysOrg.com) -- As any bench scientist will tell you, experimental design can be the very devil. Try as one might, it can be difficult to recognize, much less eliminate, the many extraneous factors that might bias an experiment. And unrecognized confounding factors can invalidate years of work.
So scientists worry. Recently Washington University in St. Louis scientist Younan Xia started to worry about in vitro experiments his lab was doing to study the uptake of nanoparticles by living cells.
In the laboratory, the cells were always plated on the bottom of a dish and the culture medium containing nanoparticles added from the top.
People assumed that if they prepared a suspension, the suspension was going to have the same concentration everywhere, including at the surface of the cells, says Xia, PhD, the James M. McKelvey Professor in the Department of Biomedical Engineering, says.
A battery of experiments in Xias lab with both upright and inverted setups showed that nanoparticles above certain sizes and weights will settle out. So concentrations of the nanoparticles near the cell surfaces are different from those in the bulk solution and cellular uptake rates are higher.
This issue is important because scientists are actively investigating the use of nanoparticles as vehicles for the delivery of drugs or genes to cells.
For these applications, calculations of the dose the particles actually convey to cells are crucially important.
As the scientists conclude in the Nature Nanotechnology article describing the experiments, Studies on the cellular uptake of nanoparticles that have been conducted with cells in the upright configuration may have given rise to erroneous and misleading data.
Topsies and Turveys
Until now nanoparticles were assumed to be well-dispersed in the culture medium because they are small enough to be easily lofted by Brownian motion, the random motion of the molecules in the medium.
Therefore scientists felt they could safely assume that the concentration of nanoparticles in the fluid next to the cells, which drives cellular uptake, was the same as the initial concentration of nanoparticles in the medium.
We started to wonder, however, because our nanoparticles are made of gold, Xia says. Gold is nontoxic but it is also very heavy, so it was conceivable relatively large nanoparticles might settle.
Since it is impossible to measure the exact concentration of gold nanoparticles at the surface of a cell, Xia and coworkers designed a simple experiment to clearly see the difference in concentration caused by sedimentation.
Xias lab tested gold nanospheres of three sizes, nanocages of two edge lengths, and nanorods, some with surface coatings that picked up serum proteins in solution and others coated with a chemical that acts as an antifouling agent.
After the cells were incubated in the nanoparticle-bearing medium, the concentration of the nanoparticles was measured spectroscopically and the number of particles each cell had taken up was then calculated.
In the literature, Xia says, there are reports that the cellular uptake of nanoparticles depends on the nanoparticles size, shape and surface coating.
His labs experiments showed that these characteristics are secondary, relevant only insofar as they affect the sedimentation and diffusion velocities of the nanoparticles.
For small, light particles, there was no disparity between the cells in the upright and the inverted configurations. In the case of larger, heavier particles, however, sedimentation dominated, and the upright cells took in more nanoparticles than the inverted cells.
All earlier work may need to be re-evaluated to account for the effects of sedimentation on nanoparticle dosimetry, the authors conclude.
Its no different from medicines that have to be shaken to suspend a powder in a water. If you dont shake the bottle, Xia says, you end up under- or overdosing yourself.
Explore further: Medical nanoparticles: local treatment of lung cancer